- Home
- FLNT vs ITRM Comparison
FLNT vs ITRM Comparison
Compare FLNT & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- ITRM
- Stock Information
- Founded
- FLNT 2001
- ITRM 2015
- Country
- FLNT United States
- ITRM Ireland
- Employees
- FLNT N/A
- ITRM N/A
- Industry
- FLNT Advertising
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- ITRM Health Care
- Exchange
- FLNT Nasdaq
- ITRM Nasdaq
- Market Cap
- FLNT 39.2M
- ITRM 40.0M
- IPO Year
- FLNT N/A
- ITRM 2018
- Fundamental
- Price
- FLNT $1.88
- ITRM $0.97
- Analyst Decision
- FLNT Hold
- ITRM Strong Buy
- Analyst Count
- FLNT 1
- ITRM 2
- Target Price
- FLNT $3.00
- ITRM $7.00
- AVG Volume (30 Days)
- FLNT 15.4K
- ITRM 501.9K
- Earning Date
- FLNT 08-18-2025
- ITRM 08-13-2025
- Dividend Yield
- FLNT N/A
- ITRM N/A
- EPS Growth
- FLNT N/A
- ITRM N/A
- EPS
- FLNT N/A
- ITRM N/A
- Revenue
- FLNT $243,850,000.00
- ITRM N/A
- Revenue This Year
- FLNT N/A
- ITRM N/A
- Revenue Next Year
- FLNT $11.62
- ITRM $270.19
- P/E Ratio
- FLNT N/A
- ITRM N/A
- Revenue Growth
- FLNT N/A
- ITRM N/A
- 52 Week Low
- FLNT $1.50
- ITRM $0.81
- 52 Week High
- FLNT $3.83
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- FLNT 46.51
- ITRM 45.02
- Support Level
- FLNT $1.85
- ITRM $0.93
- Resistance Level
- FLNT $2.10
- ITRM $1.03
- Average True Range (ATR)
- FLNT 0.10
- ITRM 0.04
- MACD
- FLNT 0.03
- ITRM 0.00
- Stochastic Oscillator
- FLNT 31.25
- ITRM 29.23
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.